{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"FGFR3, a receptor tyrosine kinase, is altered by mutation, chromosomal rearrangement or amplification in various cancers, most frequently in bladder cancer.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"11/16/2020",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "26992226"
      ]
    },
    "description":"The FGFR3 V677I mutation is located in the kinase domain of the protein. This mutation has been found in intestinal cancer. Expression of this mutation in a murine fibroblast cell line demonstrated that it is neutral as measured by no change in protein activity compared to wildtype (PMID: 26992226)",
    "knownEffect":"Likely Neutral"
  },
  "oncogenic":"Likely Neutral",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"V677I",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":2261,
    "hgvs":null,
    "hugoSymbol":"FGFR3",
    "id":null,
    "proteinEnd":677,
    "proteinStart":677,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The FGFR3 V677I mutation is likely neutral.",
  "vus":false
}